Valuation: UCB

Market Cap 47.63B 54.2B 44.46B 40.8B 76.38B 5,192B 78.26B 527B 206B 2,569B 204B 199B 8,881B P/E 2026 *
26.8x
P/E 2027 * 21.3x
Enterprise Value 47.39B 53.93B 44.23B 40.59B 75.99B 5,165B 77.86B 525B 205B 2,556B 202B 198B 8,836B EV / Sales 2026 *
5.55x
EV / Sales 2027 * 4.7x
Free-Float
61.59%
Yield 2026 *
0.59%
Yield 2027 * 0.6%
1 day+0.28%
1 week+3.12%
Current month-4.24%
1 month-4.78%
3 months+10.92%
6 months-0.83%
Current year+5.16%
1 week 238.9
Extreme 238.9
251.5
1 month 230.7
Extreme 230.7
268.3
Current year 223
Extreme 223
289.5
1 year 181.15
Extreme 181.15
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 2014-12-31
Director of Finance/CFO 59 2020-06-30
Chief Tech/Sci/R&D Officer 59 2024-04-30
Director TitleAgeSince
Director/Board Member 55 2011-12-31
Director/Board Member 67 2014-12-31
Director/Board Member 56 2014-04-23
Date Insider Type Main position Quantity % Market Cap.
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
1/15/26 Buy

Director

500 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+0.28%+3.12%+35.58%+211.60% 54.27B
+0.01%+7.10%+24.95%-6.00% 70.73B
-4.52%+47.90%+47.90%+47.90% 49.28B
+7.15%+5.51%-52.67%-51.99% 39.94B
+2.31%+7.49%+66.19%-21.33% 30.36B
-2.61%+8.97%+63.08%+98.02% 25.96B
-2.07%-6.05%+67.04%-53.63% 22.14B
-0.22%-2.66%-4.47%+145.08% 19.96B
-1.22%+1.80%+81.67%+140.36% 16.77B
+1.37%+2.16%+67.45%+129.71% 16.72B
Average +0.05%+1.84%+39.67%+63.97% 34.61B
Weighted average by Cap. +0.11%+2.42%+33.20%+56.26%

Financials

2026 *2027 *
Net sales 8.54B 9.72B 7.97B 7.32B 13.7B 931B 14.04B 94.56B 36.98B 461B 36.5B 35.71B 1,593B 9.64B 10.97B 9B 8.26B 15.46B 1,051B 15.85B 107B 41.74B 520B 41.21B 40.31B 1,798B
Net income 1.77B 2.01B 1.65B 1.52B 2.84B 193B 2.91B 19.59B 7.66B 95.48B 7.56B 7.4B 330B 2.28B 2.59B 2.13B 1.95B 3.65B 248B 3.74B 25.2B 9.86B 123B 9.73B 9.52B 425B
Net Debt -242M -276M -226M -207M -388M -26.4B -398M -2.68B -1.05B -13.06B -1.03B -1.01B -45.17B -2.32B -2.64B -2.17B -1.99B -3.73B -253B -3.82B -25.71B -10.06B -125B -9.93B -9.71B -433B
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,765
Date Price Change Volume
26-07-29 250.90 +0.28% 171,258
26-07-28 €250.20 +1.79% 227,096
26-07-27 €245.80 -0.08% 136,709
26-07-24 €246.00 +1.23% 149,516
26-07-23 €243.00 -0.12% 205,984
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
250.20EUR
Average target price
287.95EUR
Spread / Average Target
+15.09%

Quarterly revenue - Rate of surprise